ArticleJAC-antimicrobial resistance2025
Women's experiences of the assessment and management of urinary tract infections during the COVID-19 pandemic: a qualitative analysis of free-text comments from a national survey in England.
Article in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Urinary tract infections (UTIs) are one of the most common bacterial infections affecting women. The COVID-19 pandemic altered how healthcare was accessed and resulted in the rapid adoption of remote technologies. This study explored patients' experiences of consultations for UTIs in general practice during the pandemic. Methods: Women included in this study were ≥16 years, recruited via Ipsos's online panels in England, reporting at least one episode of UTI symptoms in the previous year, and had sought a consultation with a healthcare professional. We analysed 799 responses to a free-text questions, using inductive thematic analysis, regarding their experiences. Results: We identified key themes related to (i) the consultation mode and healthcare professional consulted, (ii) UTI assessment and management, (iii) validation of UTI symptoms and experience and (iv) concerns due to the COVID-19 pandemic. Positive aspects of care related to prompt and thorough assessment and treatment, consulting a healthcare professional (HCP) who validated their experience, while encouraging discussions about prevention and self-care. Negative aspects of care were related to long appointment waiting times, a lack of in-person consultation if desired and patients feeling uninformed and unvalidated about their UTIs. Conclusion: This study presents evidence that positive patient experience on UTI assessment and management is determined by the HCP involved, the mode of consultation and the application of shared decision-making to determine treatment. To improve satisfaction, systems and consultations should account for these patient preferences with shared decision-making approaches, adapted for remote consultations, to support discussions around UTI investigation and management.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.